Literature DB >> 2370855

Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin.

U Förstermann1, L D Gorsky, J S Pollock, K Ishii, H H Schmidt, M Heller, F Murad.   

Abstract

Stimulation of soluble guanylyl cyclase in rat fetal lung fibroblasts (RFL-6 cells) was used as a sensitive assay for endothelium-derived relaxing factor/nitric oxide (EDRF/NO) formation. Intact N1E-115 cells released an EDRF/NO-like material that enhanced cyclic GMP levels in RFL-6 cells. The synthesis of this substance could be stimulated with the receptor agonist neurotensin (10 microM) or by addition of the EDRF/NO substrate L-arginine (100 microM). In Ca2(+)-free Locke's solution, stimulation of EDRF/NO production by both neurotensin and L-arginine was abolished. The EDRF/NO-synthesizing activity was localized in the cytosol of N1E-115 cells. The activity was lost after boiling and it was highly sensitive to Ca2+ with the major increase in activity occurring between 100 and 500 nM Ca2+. L-Arginine and NADPH were required for maximal synthesis of EDRF/NO by the enzyme(s). The synthesis of EDRF/NO was inhibited by the following antagonists of calmodulin-regulated functions (with the approximate IC50 values given in parentheses): calmidazolium (7 microM), trifluoperazine (10 microM), fendiline (80 microM), W-7 (N-[6-aminohexyl]-5-chloro-1-naphthalenesulfonamide) (120 microM), and compound 48/80 (3 micrograms/ml). The EDRF/NO-synthesizing activity was partially purified from N1E-115 cytosol by DE 52 anion exchange chromatography. The activity was eluted with 0.1 M KCl. The enzyme(s) showed very little activity in the presence of L-arginine (100 microM) and NADPH (100 microM), but the activity could be fully restored by addition of exogenous calmodulin (EC50, approximately 2 units/ml). At 0.3 M KCl, a fraction eluted from the DE 52 column that was also able to fully restore the EDRF/NO-synthesizing activity. Thus, this fraction is likely to contain the endogenous Ca2(+)-binding protein. It is concluded that the activity of the EDRF/NO-synthesizing enzyme(s) in N1E-115 neuroblastoma cells is regulated by Ca2+ and calmodulin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370855

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  25 in total

1.  Nitric oxide synthase activity in tissues of the bovine eye.

Authors:  O Geyer; S M Podos; T Mittag
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-12       Impact factor: 3.117

2.  Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines.

Authors:  R Zeillinger; E Tantscher; C Schneeberger; W Tschugguel; S Eder; G Sliutz; J C Huber
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 3.  The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention.

Authors:  J A Molina; F J Jiménez-Jiménez; M Ortí-Pareja; J A Navarro
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

4.  Levels of protein kinase C and nitric oxide synthase activity in rats exposed to sub chronic low level lead.

Authors:  G T Ramesh; A L Jadhav
Journal:  Mol Cell Biochem       Date:  2001-07       Impact factor: 3.396

5.  Patch cramming reveals the mechanism of long-term suppression of cyclic nucleotides in intact neurons.

Authors:  Bhavya Trivedi; Richard H Kramer
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

Review 6.  Neurotensin receptors: binding properties, transduction pathways, and structure.

Authors:  J P Vincent
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

7.  Characterization of noradrenaline-stimulated cyclic GMP formation in brain astrocytes in culture.

Authors:  L Agulló; A García
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

8.  Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine.

Authors:  L J Ignarro; J M Fukuto; J M Griscavage; N E Rogers; R E Byrns
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

9.  Reductive heme-dependent activation of the n-oxide prodrug AQ4N by nitric oxide synthase.

Authors:  Clinton R Nishida; Paul R Ortiz de Montellano
Journal:  J Med Chem       Date:  2008-08-06       Impact factor: 7.446

10.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.

Authors:  J S Stamler; D I Simon; J A Osborne; M E Mullins; O Jaraki; T Michel; D J Singel; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.